Product NDC: | 0245-0071 |
Proprietary Name: | Potassium Citrate |
Non Proprietary Name: | potassium citrate |
Active Ingredient(s): | 10 meq/1 & nbsp; potassium citrate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0245-0071 |
Labeler Name: | Upsher-Smith Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019071 |
Marketing Category: | NDA |
Start Marketing Date: | 20060901 |
Package NDC: | 0245-0071-11 |
Package Description: | 100 TABLET in 1 BOTTLE (0245-0071-11) |
NDC Code | 0245-0071-11 |
Proprietary Name | Potassium Citrate |
Package Description | 100 TABLET in 1 BOTTLE (0245-0071-11) |
Product NDC | 0245-0071 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | potassium citrate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20060901 |
Marketing Category Name | NDA |
Labeler Name | Upsher-Smith Laboratories, Inc. |
Substance Name | POTASSIUM CITRATE |
Strength Number | 10 |
Strength Unit | meq/1 |
Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |